Stay informed with the latest litigation news. Explore now

IP Verse

Grnenthal competitive analysis

Latest publications and patents of Grnenthal New

Explore the latest publications and patents granted to Grnenthal, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Grnenthal

EP3995135
Jul 13, 2022Prolonged Release Dosage Form Of Tapentadol L-(+)- Tartaric Acid SaltGranted And Under Opposition
EP3210965
Nov 17, 2021Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolGranted And Under Opposition
EP3656765
Apr 14, 2021Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolGranted And Under Opposition
EP3241550
Jul 22, 2020(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful InflammationsRevoked
EP3287123
Apr 22, 2020Aqueous Pharmaceutical Formulation Of Tapentadol For Oral AdministrationRevoked
EP2694050
Oct 2, 2019Tapentadol For Treating Pain Associated With Trigeminal NeuralgiaOpposition Rejected
EP2694049
Oct 31, 2018Tapentadol For Preventing Chronification Of PainRevoked
EP2600839
Jan 10, 2018Pharmaceutical Dosage Form Comprising 6'-Fluoro-(N-Methyl- Or N,N-Dimethyl-)-4-Phenyl-4,9'-Dihydro-3'H-Spiro[Cylohexane-1,1'-Pyrano[3,4,B]Indol]-4-AmineNo Opposition Filed Within Time Limit
EP1845956
Mar 22, 2017Break-Resistant Delayed-Release Forms Of AdministrationRevoked

Latest patents of Grnenthal opposed by its competitors

Explore Grnenthal's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3995135
Jul 13, 2022Prolonged Release Dosage Form Of Tapentadol L-(+)- Tartaric Acid Salt2
EP3210965
Nov 17, 2021Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol3
EP3656765
Apr 14, 2021Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol6
EP3241550
Jul 22, 2020(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful Inflammations4
EP3287123
Apr 22, 2020Aqueous Pharmaceutical Formulation Of Tapentadol For Oral Administration1
EP2694050
Oct 2, 2019Tapentadol For Treating Pain Associated With Trigeminal Neuralgia1
EP2694049
Oct 31, 2018Tapentadol For Preventing Chronification Of Pain3
EP1845956
Mar 22, 2017Break-Resistant Delayed-Release Forms Of Administration1

Latest PTAB cases involving Grnenthal New

Discover the latest PTAB cases involving Grnenthal, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 18, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Grnenthal

PGR2018-00062Apr 18, 2018GRNENTHALANTICEP BIOVENTURES IIFinal Written Decision